Elicio Therapeutics Holds Annual Shareholder Meeting

PUBT · 1d ago
Elicio Therapeutics Holds Annual Shareholder Meeting
  • Elicio Therapeutics held its annual stockholder meeting on November 12, 2026, with both proposals adopted.
  • Stockholders elected Julian Adams, Jay R. Venkatesan and Carol Ashe to the board.
  • They also ratified Baker Tilly US as independent registered public accounting firm for the fiscal year ending December 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elicio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001601485-26-000070), on November 13, 2026, and is solely responsible for the information contained therein.